Polynovo | PNV - Sales Revenues

Stock Price
1.06
Daily Change
0 0%
Monthly
4.43%
Yearly
-22.91%
Q2 Forecast
1.17

Polynovo reported AUD70.33M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Alcidion AUD 25.47M 2.32M Dec/2025
Ansell USD 1.03B 192.2M Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Healius AUD 688.1M 245.8M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sonic Healthcare AUD 5.45B 470M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025